Coronavirus Covid-19 Information

NMIC Bulletin Vol. 23 No. 5 Update on psoriasis

4 December, 2017

Update on psoriasis

  • Psoriasis is a chronic inflammatory skin condition, resulting from a complex interplay between the immune system, genetic susceptibility and environmental triggers
  • Psoriasis is often associated with systemic co-morbidities, that may impact on management
  • Topical therapies are the mainstay of treatment for mild to moderate localised disease
  • Systemic pharmacotherapies (oral, biological) or phototherapy are needed for more severe disease, or for milder disease which fails to respond to topical therapies